Connect with us

Biotech

Aragón Invests €8.5 Million in Four Linear Accelerators

Between 2016 and 2021 the investment in the acquisition of medium and high-tech equipment in Aragonese healthcare has exceeded €43 million. Since that date, two linear accelerators have been replaced at the Clínico and a third device has been installed at the Miguel Servet. In addition to linear accelerators, the Government of Aragon is going to launch a project to implement a robotic surgery system in public hospitals.

Published

on

Aragon seeks to become stronger in the fight against cancer. The regional government, through the Aragon Health Service, has put out to tender the supply of four new linear accelerators for €8.5 million, according to the region’s contractor profile.

The cancer treatment equipment will go to the San Jorge de Huesca, Hospital Clínico, and Hospital Universitario Miguel Servet hospitals. All of them must be installed by September 2023, in accordance with the conditions set out in the Investment Plan for High-Tech Equipment of the National Health System (Inveat), through which this equipment is financed.

One of the new accelerators will be installed at the San Jorge University Hospital, the first of its kind in the province. The other three units will be used to replace equipment that had become obsolete, two at the Miguel Servet University Hospital and one at the Lozano Blesa Clinic.

Read more on the subject and find the most important business news with the Born2Invest mobile app.

Aragon has a budget of €26.5 million for renewing healthcare technology

Thus, within a year, the Community will have seven public linear accelerators to be able to carry out radiotherapy treatments. To these will be added the eighth piece of equipment to be installed in the new Teruel Hospital, which will be acquired outside the Inveat Plan.

The four linear accelerators are part of the 28 pieces of equipment that the Aragonese Health Service is to acquire through the Inveat Plan, thanks to which Aragon has a budget of €26.5 million for renewing healthcare technology.

SEE ALSO  Communal Capital Fund: Success of the bond issue of 2 MMDH

The objectives of this plan are basically twofold. On the one hand, to reduce the obsolescence of the technological park of high-tech equipment, for which the plan is to renew equipment that is twelve years old or more, as well as accelerators and computerized tomagrafrías between ten and eleven years old. On the other hand, the aim is to raise by at least 15% the average density rate of high-tech equipment per 100,000 inhabitants, in order to improve equity in access to these technologies, according to the regional Executive.

Investment in high technology in Aragon has exceeded €43 million in the last five years

In addition to linear accelerators, the Government of Aragon is going to launch a project to implement a robotic surgery system in public hospitals. This project will enable patients requiring high-precision interventions to benefit from the advantages of robotic surgery in terms of fewer side effects and sequelae, as well as favoring faster patient recovery. The Health Department expects the first two devices to be acquired to be installed in 2023.

Between 2016 and 2021 the investment in the acquisition of medium and high-tech equipment in Aragonese healthcare has exceeded €43 million. Since that date, two accelerators have been replaced at the Clínico and a third device has been installed at the Miguel Servet.

__

(Featured image by geralt via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Anthony Donaghue writes about science and technology. Keeping abreast of the latest tech developments in various sectors, he has a keen interest on startups, especially inside and outside of Silicon Valley. From time to time, he also covers agritech and biotech, as well as consumer electronics, IT, AI, and fintech, among others. He has also written about IPOs, cannabis, and investing.